Eva Harth

Find an error

Name: Harth, Eva
Organization: Vanderbilt University , USA
Department:
Title: (PhD)
Co-reporter:Kui Huang;Teresa A. Croce;Sharon K. Hamilton;Chinessa T. Adkins;Billie L. Evans III
Macromolecular Symposia 2007 Volume 255(Issue 1) pp:20-23
Publication Date(Web):12 SEP 2007
DOI:10.1002/masy.200750903

Summary: The development of suitable delivery systems for intracellular delivery of proteins, peptides and other bioactive materials opens the possibility to establish refined strategies for small drug delivery, gene delivery and vaccination. We present the assembly of advanced drug delivery systems from tailored building blocks to scaffolds and bioactive cargos to afford targeting and transport across biological barriers. In particular, the utilization of novel molecular transporter will advance the bioavailability of small and macromolecular drugs that show targeted intracellular delivery.

N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide
Butanedinitrile,2,3-bis[amino[(2-aminophenyl)thio]methylene]-
7-(Diethylamino)-3-(1-methyl-1H-benzo[d]imidazol-2-yl)-2H-chromen-2-one
5H-Benzo[a]phenoxazin-5-one,9-(diethylamino)-